Baseline Expression of Exosomal miR-92a-3p and miR-221-3p Could Predict the Response to First-Line Chemotherapy and Survival in Metastatic Colorectal Cancer
暂无分享,去创建一个
O. Bălăcescu | C. Vlad | S. Căinap | C. Căinap | A. Gherman | C. Popa | L. Balacescu
[1] S. Wong,et al. Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities , 2023, Cancers.
[2] Ziyue Wang,et al. MicroRNAs (miRNAs): Novel potential therapeutic targets in colorectal cancer , 2022, Frontiers in Oncology.
[3] L. Barbu-Tudoran,et al. Circulating Small EVs miRNAs as Predictors of Pathological Response to Neo-Adjuvant Therapy in Breast Cancer Patients , 2022, International journal of molecular sciences.
[4] R. Hajjo,et al. Unlocking the Potential of the Human Microbiome for Identifying Disease Diagnostic Biomarkers , 2022, Diagnostics.
[5] M. Neganova,et al. Perspectives of using microRNA-loaded nanocarriers for epigenetic reprogramming of drug resistant colorectal cancers. , 2022, Seminars in cancer biology.
[6] Abdul Quaiyoom Khan,et al. Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer , 2022, Journal of experimental & clinical cancer research : CR.
[7] Wei Wang,et al. LncRNA LINC01315 silencing modulates cancer stem cell properties and epithelial-to-mesenchymal transition in colorectal cancer via miR-484/DLK1 axis , 2022, Cell cycle.
[8] W. Cho,et al. Colorectal cancer cell-derived extracellular vesicles transfer miR-221-3p to promote endothelial cell angiogenesis via targeting suppressor of cytokine signaling 3. , 2021, Life sciences.
[9] A. Fernández-Santander,et al. miR-7, miR-10a and miR-143 Expression May Predict Response to Bevacizumab Plus Chemotherapy in Patients with Metastatic Colorectal Cancer , 2021, Pharmacogenomics and personalized medicine.
[10] Jia Liu,et al. Exosome‐delivered miR‐221/222 exacerbates tumor liver metastasis by targeting SPINT1 in colorectal cancer , 2021, Cancer science.
[11] T. Senda,et al. Circulating microRNA-92a-3p in colorectal cancer: a review , 2021, Medical Molecular Morphology.
[12] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[13] Yang Li,et al. Human Gut Microbiome-Based Knowledgebase as a Biomarker Screening Tool to Improve the Predicted Probability for Colorectal Cancer , 2020, Frontiers in Microbiology.
[14] G. Sammarco,et al. Mast Cells, microRNAs and Others: The Role of Translational Research on Colorectal Cancer in the Forthcoming Era of Precision Medicine , 2020, Journal of clinical medicine.
[15] H. Verheul,et al. A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancer , 2020, Cancer medicine.
[16] M. Kattan,et al. Cohort Studies: Design, Analysis, and Reporting. , 2020, Chest.
[17] A. Irimie,et al. Current and New Predictors for Treatment Response in Metastatic Colorectal Cancer. The Role of Circulating miRNAs as Biomarkers , 2020, International journal of molecular sciences.
[18] C. Garrido,et al. Exosomal miRNA: Small Molecules, Big Impact in Colorectal Cancer , 2019, Journal of oncology.
[19] Yan Ding,et al. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer , 2019, Molecular Cancer.
[20] G. Banfi,et al. Normalization strategies differently affect circulating miRNA profile associated with the training status , 2019, Scientific Reports.
[21] K. Redalen,et al. An experimental strategy unveiling exosomal microRNAs 486-5p, 181a-5p and 30d-5p from hypoxic tumour cells as circulating indicators of high-risk rectal cancer , 2019, Journal of extracellular vesicles.
[22] A. Irimie,et al. The Impact of miRNA in Colorectal Cancer Progression and Its Liver Metastases , 2018, International journal of molecular sciences.
[23] Yu-qin Pan,et al. DNA-methylation-mediated silencing of miR-486-5p promotes colorectal cancer proliferation and migration through activation of PLAGL2/IGF2/β-catenin signal pathways , 2018, Cell Death & Disease.
[24] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[25] K. To,et al. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside , 2018, World journal of gastroenterology.
[26] Zhi Chen,et al. Circulating Exosomal miR-17-5p and miR-92a-3p Predict Pathologic Stage and Grade of Colorectal Cancer , 2018, Translational oncology.
[27] E. Scarpi,et al. Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer , 2018, International journal of molecular sciences.
[28] C. Zhan,et al. MicroRNA-146a promote cell migration and invasion in human colorectal cancer via carboxypeptidase M/src-FAK pathway , 2017, Oncotarget.
[29] J Ricke,et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[30] Yong Peng,et al. The role of MicroRNAs in human cancer , 2016, Signal Transduction and Targeted Therapy.
[31] T. Chervenkov,et al. Serum expression levels of miR-17, miR-21, and miR-92 as potential biomarkers for recurrence after adjuvant chemotherapy in colon cancer patients. , 2015, Bioscience trends.
[32] P. Wei,et al. MiR-92a Promotes Cell Metastasis of Colorectal Cancer Through PTEN-Mediated PI3K/AKT Pathway , 2015, Annals of Surgical Oncology.
[33] K. Mimori,et al. Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer , 2015, British Journal of Cancer.
[34] Shuo Yan,et al. MicroRNAs in colorectal cancer: potential biomarkers and therapeutic targets. , 2015, Frontiers in bioscience.
[35] I. Nagtegaal,et al. MicroRNA-143 is a putative predictive factor for the response to fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer , 2015, Oncotarget.
[36] Yong Yu,et al. Expression of miR-221 in colon cancer correlates with prognosis. , 2015, International journal of clinical and experimental medicine.
[37] George A Calin,et al. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. , 2014, Cancer cell.
[38] H. Ling,et al. MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer. , 2014, World journal of gastroenterology.
[39] Weiying Zhou,et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. , 2014, Cancer cell.
[40] O. Lingjaerde,et al. Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first‐line oxaliplatin‐based treatment , 2014, Molecular oncology.
[41] Lesley Cheng,et al. Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood , 2014, Journal of extracellular vesicles.
[42] A. Schetter,et al. MicroRNAs and Inflammation in the Pathogenesis and Progression of Colon Cancer , 2012, Digestive Diseases.
[43] M. Bushell,et al. microRNAs in cancer management. , 2012, The Lancet. Oncology.
[44] J. Lötvall,et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.
[45] M. Sheikhha,et al. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance. , 2019, Cancer biomarkers : section A of Disease markers.